Wei Cui
- Endocrine and Autonomic Systems top 10%
- Epidemiology top 10%
- Adipokines, Inflammation, and Metabolic Diseases 6
- Physiology top 10%
- Adipose Tissue and Metabolism 10
- Immunology top 10%
- Biochemistry top 10%
-
- Peroxisome Proliferator-Activated Receptors 8
- Metabolism, Diabetes, and Cancer 5
- Receptor Mechanisms and Signaling 4
-
- Inflammatory mediators and NSAID effects 5
-
- Metabolism and Genetic Disorders 3
-
- Tracheal and airway disorders 3
- Co-authors
- Ke‐Qin HuRobin MacLarenKatherine CianfloneDavid KalantSerge SimardStéphane A. LaporteChanghong YuPeter N. Monk
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Wei Cui
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Endocrine and Autonomic Systems 91
- Epidemiology 439
- Physiology 310
- Immunology 233
- Biochemistry 76
Countries citing papers authored by Wei Cui
This map shows the geographic impact of Wei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Cui more than expected).
Fields of papers citing papers by Wei Cui
This network shows the impact of papers produced by Wei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Cui. The network helps show where Wei Cui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 2 | |
| 7 | 2020 | 10 | |
| 8 | 2016 | 13 | |
| 9 | 2016 | 20 | |
| 10 | 2015 | 12 | |
| 11 | 2011 | 5 | |
| 12 | 2011 | 89 | |
| 13 | 2010 | 61 | |
| 14 | 2009 | 39 | |
| 15 | 2009 | 26 | |
| 16 | 2008 | 47 | |
| 17 | 2008 | 12 | |
| 18 | 2007 | 46 | |
| 19 | 2006 | 34 | |
| 20 | [Thoracic high resolution CT findings of 100 SARS patients in convalescent period]. | 2003 | 9 |
About Wei Cui
Wei Cui is a scholar working on Physiology, Clinical Biochemistry and Physiology, having authored 55 papers that have together received 1.5k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (10 papers), Peroxisome Proliferator-Activated Receptors (8 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Inflammatory mediators and NSAID effects (5 papers), Receptor Mechanisms and Signaling (4 papers), Metabolism and Genetic Disorders (3 papers) and Tracheal and airway disorders (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (91 citations), Epidemiology (439 citations) and Physiology (310 citations). Wei Cui has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Ke‐Qin Hu, Robin MacLaren, Katherine Cianflone, Katherine Cianflone, David Kalant, Serge Simard, Stéphane A. Laporte, Changhong Yu, Katherine Cianflone and Peter N. Monk. Their work appears in journals such as Vaccine, Nutrients, Analytical Chemistry, Molecular Immunology and Acta Biochimica et Biophysica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.